We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRUS market cap is 3.19B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.03M | 8.94M | 7.89M | 7.33M | 11.77M |
| Operating Income | -38.37M | -98.52M | -46.81M | -69.17M | -72.23M |
| Net Income | -23.01M | -60.15M | -34.46M | -50.04M | -99.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 31.13M | 29.94M | 49.11M | 41.59M | 43.95M |
| Operating Income | -58.66M | -75.88M | -89.98M | -160.04M | -156.55M |
| Net Income | -55.15M | -85.51M | -66.82M | -131.19M | -154.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 492.19M | 455.49M | 498.08M | 892.23M | 844.68M |
| Total Liabilities | 98.8M | 99.15M | 148.64M | 145.46M | 141.42M |
| Total Equity | 393.39M | 356.34M | 349.45M | 746.77M | 703.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 263.38M | 231.22M | 456.6M | 376.54M | 455.49M |
| Total Liabilities | 132.08M | 128.95M | 140.4M | 129.49M | 99.15M |
| Total Equity | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -105.86M | -142.21M | -44.39M | -38.76M | -119.18M |
| Investing | -24.9M | -27.02M | -12.08M | -8.85M | -142.52M |
| Financing | 228.59M | 230.09M | 30.16M | 475.05M | 485.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -63.05M | -79.9M | -59.63M | -149.9M | -142.21M |
| Investing | 24.17M | -1.49M | -146.62M | 2.8M | -27.02M |
| Financing | 74.23M | 39.52M | 281.96M | 58.74M | 230.09M |
| Market Cap | 3.19B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 68.46M |
| Average Volume (1 week) | 311.16k |
| Average Volume (1 Month) | 360.06k |
| 52 Week Change | 93.60% |
| 52 Week High | 61.61 |
| 52 Week Low | 22.26 |
| Spread (Intraday) | 8.22 (15.16%) |
| Company Name | Merus NV |
| Address |
uppsalalaan 17 utrecht, utrecht 3584 CT |
| Website | https://www.merus.nl |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
